BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 19586764)

  • 1. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
    Haidari M; Ali M; Ward Casscells S; Madjid M
    Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
    Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-influenza activity of Alchemilla mollis extract: possible virucidal activity against influenza virus particles.
    Makau JN; Watanabe K; Kobayashi N
    Drug Discov Ther; 2013 Oct; 7(5):189-95. PubMed ID: 24270383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 6. Germacrone inhibits early stages of influenza virus infection.
    Liao Q; Qian Z; Liu R; An L; Chen X
    Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses.
    Shin WJ; Lee KH; Park MH; Seong BL
    Microbiol Immunol; 2010; 54(1):11-9. PubMed ID: 20055938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Clinacanthus siamensis leaf extract on influenza virus infection.
    Wirotesangthong M; Nagai T; Yamada H; Amnuoypol S; Mungmee C
    Microbiol Immunol; 2009 Feb; 53(2):66-74. PubMed ID: 19291089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
    Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
    Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; KoƂodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity of Peanut (Arachis hypogaea L.) Skin Extract Against Human Influenza Viruses.
    Makau JN; Watanabe K; Mohammed MMD; Nishida N
    J Med Food; 2018 Aug; 21(8):777-784. PubMed ID: 29847745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient.
    Cohen-Daniel L; Zakay-Rones Z; Resnick IB; Shapira MY; Dorozhko M; Mador N; Greenbaum E; Wolf DG
    J Clin Virol; 2009 Feb; 44(2):138-40. PubMed ID: 19157971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
    Ehrhardt C; Hrincius ER; Korte V; Mazur I; Droebner K; Poetter A; Dreschers S; Schmolke M; Planz O; Ludwig S
    Antiviral Res; 2007 Oct; 76(1):38-47. PubMed ID: 17572513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong.
    Leung TW; Tai AL; Cheng PK; Kong MS; Lim W
    J Clin Virol; 2009 Nov; 46(3):298-9. PubMed ID: 19736041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.